Use of 5-ARIs May Decrease Bladder Cancer Risk
A study examined bladder cancer risk and mortality among nearly 100,000 men from Ontario, Canada, who received 5-alpha reductase inhibitors.
Benign Prostatic Hyperplasia
Water Vapor Therapy for BPH Safe, Effective in Large Real-World Study
Rezūm therapy significantly improved symptoms, urinary flow, and quality of life in men across a wide range of prostate sizes, data show.
Rise in Prostatic Urethral Lift Use for BPH Reported
The procedure is now performed in one-third of all surgeries for benign prostatic hyperplasia, a study found.
5-ARIs Do Not Increase Prostate Cancer Mortality
Data on whether 5-ARIs increase the risk of prostate cancer-specific mortality have been mixed.
BPH Surgical Outcomes Worse After PAE vs TURP, PUL
Prostatic artery embolization is a minimally invasive surgical technique that involves selective cannulation of the prostatic arteries.
Male Lower Urinary Tract Symptoms Up Death Risk
Bothersome or not, lower urinary tract symptoms increase mortality risk in men.
Larger Prostates Up Odds of Converting From HoLEP to Open Prostatectomy
The likelihood of conversion from HoLEP to an open procedure to treat benign prostatic hyperplasia increases along with prostate size.
Entadfi Approved for Benign Prostatic Hyperplasia
Entadfi is a fixed-dose combination of finasteride, a 5α-reductase inhibitor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor.
Investigators: Consider 5-ARI Use When Deciding on Prostate Biopsy
At prostate cancer diagnosis, clinical T stage was significantly higher among 5-ARI users compared with nonusers.
Fewer Complications After Laser Enucleation of the Prostate
Laser enucleation of the prostate accounts for less than 5% of all BPH procedures performed in the US.
- Loading...
Loading...
Next post in AUA2021 Virtual Experience
Loading... 
Loading...